Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
481. |
ECCT/11/12/04 | PENNVAX-G DNA/MVA HIV Vaccine Phase 1 trial A Phase I Study of the Safety and Immunogenicity of PENNVAX™-G DNA (Env & Gag) Administered by Intramuscular Biojector® 2000 or by CELLECTRA® Intramuscular Electroporation Device Followed by MVACMDR (HIV-1 CM235 env/ CM240 gag/pol) Boost in Healthy, HIV Uninfected Adults |
Principal Investigator(s) 1. FREDRICK KIPYEGO SAWE Site(s) in Kenya KEMRI/Walter Reed Project-Kericho |
View |
482. |
ECCT/09/06/02 | A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy plus HIV Primary Care versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 In Serodiscordant Couples |
Principal Investigator(s) 1. Lisa Ann Mills Site(s) in Kenya Kisumu, Kenya |
View |
483. |
ECCT/11/07/02 | REMEMBER A5274/REMEMBER "Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment Regimens" |
Principal Investigator(s) 1. Abraham Mosigisi Siika Site(s) in Kenya 1. Moi University Clinical Research Centre (Uasin Gishu county) 2. Walter Reed Project (Kericho county) |
View |
484. |
ECCT/13/05/02 | An open-label randomized controlled trial of the efficacy and safety of Clindamycin plus quinine compared with artemether-lumefantrine for the treatment of children with uncomplicated falciparum malaria in western Kenya |
Principal Investigator(s) 1. CHARLES OWUORA OBONYO Site(s) in Kenya Ahero Sub-district Hospital |
View |
485. |
ECCT/11/10/05 | A Phase 3, Open Label, Randomized, Comparative Study to Evaluate Azithromycin Plus Chloroquine and Sulfadoxine Plus Pyrimethamine Combinations for Intermittent Preventive Treatment of Falciparum Malaria Infection in Pregnant Women in Africa. WRAIR #1775, KEMRI SSC #1983 |
Principal Investigator(s) 1. Lucas Otieno Tina Site(s) in Kenya 1. KEMRI/WRP Kombewa (Kisumu county) |
View |